Next Article in Journal
Mechanistic and Clinical Evidence Supports a Key Role for Cell Division Cycle Associated 5 (CDCA5) as an Independent Predictor of Outcome in Invasive Breast Cancer
Next Article in Special Issue
Immune Microenvironment and Immunotherapies for Diffuse Intrinsic Pontine Glioma
Previous Article in Journal
CYP1B1: A Novel Molecular Biomarker Predicts Molecular Subtype, Tumor Microenvironment, and Immune Response in 33 Cancers
Previous Article in Special Issue
ERK Inhibitor Ulixertinib Inhibits High-Risk Neuroblastoma Growth In Vitro and In Vivo
 
 
Article

Article Versions Notes

Cancers 2022, 14(22), 5642; https://doi.org/10.3390/cancers14225642
Action Date Notes Link
article xml file uploaded 17 November 2022 07:38 CET Original file -
article xml uploaded. 17 November 2022 07:38 CET Update https://www.mdpi.com/2072-6694/14/22/5642/xml
article pdf uploaded. 17 November 2022 07:38 CET Version of Record https://www.mdpi.com/2072-6694/14/22/5642/pdf
article supplementary file uploaded. 17 November 2022 07:38 CET - https://www.mdpi.com/2072-6694/14/22/5642#supplementary
article html file updated 17 November 2022 07:39 CET Original file -
article html file updated 28 February 2023 23:24 CET Update -
article html file updated 3 March 2023 20:37 CET Update https://www.mdpi.com/2072-6694/14/22/5642/html
Back to TopTop